Inactive Instrument

Press Releases Forma Therapeutics Holdings, Inc.

Equities

FMTX

US34633R1041

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

Novo Nordisk announces the completion of the Forma Therapeutics acquisition	22-10-17	AQ
FORMA THERAPEUTICS HOLDINGS, INC. : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	22-10-14	AQ
Sickle Cell Disease Association of America & Partners Launch New PSA to Boost Awareness and Understanding of the Disease	22-09-30	BU
FORMA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Forma Therapeutics, Holdings Inc. - FMTX	22-09-27	BU
Forma Therapeutics : Amendment to Initial Statement of Beneficial Ownership - Form 3/A	22-09-19	PU
FORMA THERAPEUTICS INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Forma Therapeutics, Holdings Inc. - FMTX	22-09-02	BU
Nvidia, Hormel fall; Nutanix, Forma Therapeutics rise	22-09-01	AQ
FORMA THERAPEUTICS HOLDINGS, INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	22-09-01	AQ
Novo Nordisk to acquire Forma Therapeutics and expand presence in sickle cell disease and rare blood disorders	22-09-01	BU
Forma Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update	22-08-08	AQ
FORMA THERAPEUTICS HOLDINGS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	22-08-05	AQ
Forma Therapeutics : Reports Second Quarter 2022 Financial Results and Provides Business Update - Form 8-K	22-08-05	PU
FORMA THERAPEUTICS HOLDINGS, INC. : Results of Operations and Financial Condition (form 8-K)	22-08-05	AQ
Forma Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update	22-08-05	BU
Forma Therapeutics to Report Second Quarter 2022 Financial Results and Provide Business Update on August 5, 2022	22-07-29	BU
FORMA THERAPEUTICS HOLDINGS, INC. : Change in Directors or Principal Officers (form 8-K)	22-07-25	AQ
Forma Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)	22-07-12	BU
Forma Therapeutics Announces Appointment of New Executive Team Members	22-06-30	BU
Forma Therapeutics Announces Presentations at Upcoming Hematology Conferences	22-06-10	BU
FORMA THERAPEUTICS HOLDINGS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	22-06-09	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Forma Therapeutics Holdings, Inc.

Equities

FMTX

US34633R1041

Press Releases

Filters